Singapore, May 18 -- Shanghai Fosun Pharmaceutical (Group) and South Korea-based AriBio Co., a biopharmaceutical company focused on neurodegenerative diseases, have jointly announced the signing of an... Read More
Singapore, May 18 -- ImmunityBio, Inc., a commercial-stage immunotherapy company, has announced an exclusive US Development and Supply Agreement with Japan BCG Laboratory (JBL), the Tokyo-based develo... Read More
Singapore, May 18 -- South Korea-based LOTTE Biologics has announced an expansion of its collaboration with UK-based Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 d... Read More
Singapore, May 18 -- The University of Sydney will offer its medical students the chance to study the Doctor of Medicine degree on a part-time basis, the first university in Australia to do so.The par... Read More
Singapore, May 18 -- Most pharma digitalisation projects never leave the pilot stage. AUTOMA+ 2026 is built for the ones that do. Fragmented systems, unclear ROI and weak operational integration under... Read More
Singapore, May 15 -- The Research Institute for Cancer Prevention, Screening and Early Detection (RISE), jointly led by the National Cancer Centre Singapore (NCCS) and NTU Singapore, has announced the... Read More
Singapore, May 15 -- The Department of Health - Abu Dhabi (DoH), regulator of the healthcare sector in the emirate, together with the Abu Dhabi Public Health Center (ADPHC), has announced the executio... Read More
Singapore, May 15 -- NinaMED, a newly formed Australian medical device company, has announced its establishment and $13.75 million (AUD $19 million) in financing led by SPRIM Global Investments (SGI).... Read More
Singapore, May 15 -- METiS TechBio, a tech-bio company focused on AI-powered nanodelivery innovation, has successfully listed on the Hong Kong Stock Exchange (HKEX), becoming the world's first publicl... Read More
Singapore, May 15 -- Fujitsu Limited and IBM Japan have announced the formalisation of a collaboration within the healthcare domain, building on considerations first announced in September 2025. To a... Read More